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Abstract 26 
Introduction: The epithelial and endothelial barriers of the airway mucosa are 27 
critical for regulation of tissue homeostasis and protection against pathogens or 28 
other tissue damaging agents. In response to a viral infection, epithelial cells must 29 
signal to the endothelium to initiate immune cell recruitment. This is a highly 30 
temporal regulated process; however, the mechanisms of this cross-talk are not fully 31 
understood.  32 
Methods: In a close-contact co-culture model of human airway epithelial and 33 
endothelial cells cellular crosstalk was analysed using transepithelial electrical 34 
resistance (TER) measurements, immunofluorescence, electron microscopy and 35 
ELISA. Viral infections were simulated by exposing airway epithelial cells apically to 36 
double-stranded RNA (Poly(I:C)). Using a microfluidic culture system the temporal 37 
release of mediators was analysed in the co-culture model.  38 
Results: Within 4h of challenge, double-stranded RNA induced the release of TNF-α 39 
by epithelial cells. This activated endothelial cells by triggering the release of the 40 
chemoattractant CX3CL1 (fractalkine) by 8h post-challenge and expression of 41 
adhesion molecules E-selectin and ICAM-1. These responses were significantly 42 
reduced by neutralising TNF-α.  43 
Conclusion: By facilitating kinetic profiling, the microfluidic co-culture system has 44 
enabled identification of a key signalling mechanism between the epithelial and 45 
endothelial barriers. Better understanding of cell-cell cross-talk and its regulatory 46 
mechanisms has the potential to identify new therapeutic strategies to control airway 47 
inflammation. 48 
 49 
Key words: cellular crosstalk, airway epithelial barrier, endothelial barrier, Tumor 50 
necrosis factor alpha, fractalkine (CX3CL1)51 
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Introduction 52 
With an estimated surface area of around 140m2, the lung is the organ with the 53 
largest interface with the external environment (1). During inspiration, the lung 54 
epithelial surface is exposed to a variety of naturally occurring and anthropogenic 55 
substances with potential to do harm. However, the filtering and innate protective 56 
mechanisms of the airways inactivate and/or remove most of these substances 57 
without any need for immune cell activation (2). As well as contributing to tissue 58 
homeostasis through its barrier functions, the airway epithelium must be able to 59 
respond appropriately when it is compromised by signalling to cells of the innate and 60 
adaptive immune system (3). These immune cells may reside locally, or be recruited 61 
from the circulation via endothelial cell activation. Although the mechanisms of 62 
epithelial-endothelial crosstalk are not fully understood, communication can be 63 
achieved through release of a variety of mediators including cytokines, chemokine, 64 
growth factors, lipids and other small molecules such as reactive oxygen species 65 
(ROS) or nitric oxide (NO) (2). The integrated responses arising from this cell-cell 66 
communication can be observed readily in animal models in vivo, however in vitro 67 
models using human cells are more amenable for dissection of mechanisms of cell-68 
cell communication and identification of key cell-type specific mediators with 69 
relevance to human disease (4). 70 
Traditionally, cellular crosstalk has be analysed in vitro using conditioned media from 71 
one cell type to stimulate second cell type. For example, by using conditioned media 72 
from endothelial cells, it has been shown that lung endothelial cells improve the 73 
physical barrier properties of alveolar epithelial cells, while factors from brain-derived 74 
endothelial cells diminish the epithelial barrier (5). However, use of conditioned 75 
media overlooks the close spatial relationship between individual cell types within a 76 
tissue, especially direct cell-cell contacts. Crucially, it neglects the temporal evolution 77 
of mediator release. Consequently, co-culture models of different cell types have 78 
been developed to reflect the in vivo situation more closely. In most cases, the cell 79 
types were separated by a permeable filter support, with one cell type cultured in the 80 
apical and the other in the basolateral compartment. For example, in vitro models of 81 
the air-blood-barrier consisting of lung epithelial and endothelial cells have been 82 
used to study the mechanisms of acute lung injury (6). Air-blood-barrier models have 83 
also been used to analyse the passage of nanoparticles across the barrier and to 84 
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evaluate their immune-modulatory capacity (7-9). These improved models have led 85 
to the proposal that airway epithelial-endothelial co-culture models have the potential 86 
to replace in vivo animal studies for analysis of pulmonary toxicity (10).  87 
While commonly used co-culture models represent an advance, these models lack 88 
the constant exchange of metabolites or diffusion of mediators by the circulation as 89 
observed in vivo. To address this problem, we have developed a dynamic 90 
microfluidic culture system which mimics interstitial flow, enabling supply of nutrients, 91 
removal of metabolites and analysis of time-dependent mediator release with much 92 
higher sensitivity (11). In the current study, we have exploited this system to analyse 93 
the temporal crosstalk between lung epithelial and endothelial cellular barriers in 94 
response to respiratory viral infections. We hypothesised that the epithelium senses 95 
the infections and activates endothelial cells to facilitate immune cell infiltration. We 96 
utilised a microfluidic culture system comprising of a close-contact epithelial-97 
endothelial co-culture exposed to double stranded RNA, a virus-associated 98 
molecular pattern. We found that epithelial-derived TNF-α activated endothelial cells 99 
to release CX3CL1, a chemotactic molecule for monocytes, NK cells and CD4
+ T 100 
lymphocytes (12, 13). The analysis of cellular crosstalk and the kinetics of mediator 101 
release are important in order to understand the regulation of tissue homeostasis. 102 
This approach provides insight into the underlying mechanisms of cellular pathology 103 
in diseases including asthma and chronic obstructive pulmonary disease thereby 104 
helping to identify therapeutic targets. 105 
 106 
Materials and Methods 107 
Cell culture. All procedures for the collection of human umbilical cords and isolation 108 
of human umbilical vein endothelial cells (HUVECs) were approved by the 109 
Southampton and South West Hampshire Research Ethics Committee (REC Ref: 110 
07/H0502/83). HUVECs were isolated from human umbilical cords as previously 111 
described (14). Briefly, the veins of umbilical cords were incubated with Type I 112 
collagenase solution (1mg/ml) for 10min to remove endothelial cells. Cells in solution 113 
were centrifuged and cultured on gelatin-coated tissue culture flasks in endothelial 114 
culture medium (M199 medium supplemented with L-Glutamine, 115 
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penicillin/streptomycin (Life technologies, Paisley, UK) and 20% human serum) until 116 
~80% confluent; Experiments were performed with endothelial cells in passage 1. 117 
The human bronchial epithelial cell line, 16HBE14o- (a gift from Prof. D.C. Gruenert, 118 
San Francisco, USA), was maintained in epithelial medium (minimum essential 119 
medium (MEM) with Glutamax and supplemented with 10% foetal bovine serum and 120 
penicillin/streptomycin (Life technologies, Paisley, UK)). Cell culture flasks were 121 
coated with PureCol collagen I (Advanced BioMatrix, San Diego, CA, USA). All 122 
experiments were performed with epithelial cells for no more than 20 passages in 123 
culture. 124 
Epithelial-endothelial co-culture. Transwell® polyester membrane cell culture inserts 125 
(6.5mm diameter, 0.4µmpore size; Corning Life Sciences, Amsterdam, The 126 
Netherlands) were used for culturing human airway epithelial and endothelial cells. 127 
Airway epithelial cells were cultured on the apical side and endothelial cells on the 128 
basal side of the permeable culture insert. After coating both sides of the membrane 129 
with collagen, inserts were turned upside-down and 5 x 104 HUVECs in a volume of 130 
50µl endothelial medium were seeded on the basal side of the membrane. 131 
Endothelial cells were left in a humidified incubator at 37°C, 5% CO2 for 2h to adhere. 132 
Non-adherent cells were gently washed off and the inserts replaced into a 24-well 133 
plate with 500µl endothelial medium in the basolateral compartment. Airway 134 
epithelial cells were seeded in the apical compartment at a density of 1.5 x 105 cells 135 
in 200µl epithelial cell medium. Cells were co-cultured for up to 8 days and media 136 
was changed every 2-3 days. The formation of the physical barrier was monitored by 137 
measuring the ionic permeability by transepithelial resistance (TER) using an EVOM 138 
voltohmmeter (World Precision Instruments, Aston, UK). TER measurements were 139 
corrected for the resistance of an empty Transwell (170Ω) and were expressed as 140 
Ω*cm2. 141 
Transmission Electron microscopy. Cell culture inserts were fixed with 3% 142 
glutaraldehyde and 4% paraformaldehyde in 0.1M PIPES buffer and contrast stained 143 
with 1% osmium tetroxide and 2% uranyl acetate in 0.1M PIPES buffer. After 144 
dehydration in ethanol and acetonitrile, the membranes were embedded in Spurr 145 
resin. Ultrathin sections (~60nm) were stained with Reynolds’ lead citrate stain and 146 
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analysed with a H7000 transmission electron microscope (Hitachi High-Technologies 147 
Europe GmbH, Maidenhead, UK). 148 
Immunofluorescence staining. For immunofluorescence staining, cells were fixed in 149 
4% paraformaldehyde, permeabilized with 0.1% Triton X-100 and blocked with 1% 150 
BSA in PBS. Membranes were cut from the inserts and epithelial cells were stained 151 
with a mouse anti-human occludin-AlexaFluor488 (clone OC-3F10, Life technologies, 152 
Paisley, UK) and Acti-stain 555 phalloidin-(Cytoskeleton Inc., Denver, CO, US). 153 
Endothelial cells were stained with mouse anti-human ICAM-1 and E-selectin 154 
monoclonal antibodies (clone BBIG-I1 and BBIG-E1 respectively, R&D Systems, 155 
Abingdon, UK) and AlexaFluor®488 conjugated goat anti-mouse IgG1 secondary 156 
antibody (Life technologies, Paisley, UK). Actin filaments were stained using Acti-157 
stain 555 phalloidin. Stained membranes were mounted on slides using ProLong 158 
Gold antifade reagent with DAPI (Life technologies) and analysed with a LSM6000 159 
microscope (Leica Microsystems, Wetzlar, Germany). z-Stacks were deconvoluted 160 
using Leica Application Suite software and z-projections and orthogonal views were 161 
performed using ImageJ software. 162 
Microfluidic culture system. The design, fabrication and validation of the microfluidic 163 
culture system has been described in detail previously (11). After 6 days in co-164 
culture, cells on inserts were transferred to microfluidic culture device and perfused 165 
with endothelial medium at a flow rate of 30µl/h (Fig. 1). Following an equilibration 166 
phase of 1h, epithelial cells were apically exposed to 5µg/ml Poly(I:C) (HMW, 1.5kb 167 
to 8kb, Invivogen, Toulouse, France) to mimic a viral infection. Basolateral secretions 168 
were collected with an automated fraction collector every 2h for a period of 24h. 169 
Control experiments were performed under static culture conditions in 24-well plates 170 
with 200µl apical and 500µl basolateral medium. 171 
Release of mediators. The release of TNF-α and CX3CL1 (fractalkine) into the 172 
basolateral medium was analysed by ELISA using Human TNF-alpha DuoSet and 173 
Human CX3CL1/Fractalkine DuoSet kits (R&D Systems, Abingdon, UK). For blocking 174 
experiments, the soluble TNF-α receptor fusion protein, Enbrel (Wyeth Europa Ltd, 175 
Maidenhead, UK) was added to the apical and basolateral medium at a 176 
concentration of 10µg/ml, 1h prior stimulation.  177 
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Macromolecular permeability. FITC-labelled dextran with an average molecular 178 
weight of 4kDa was added to the apical medium at a concentration of 2mg/ml for the 179 
last 3h of stimulation. The amount of FITC-dextran passage to the basolateral 180 
compartment was analysed by measuring the fluorescence intensity and taken as a 181 
measure of macromolecular permeability.  182 
Statistical analysis. Statistical evaluation was performed using the software 183 
SigmaPlot 12.5. If not stated otherwise, related samples were analysed for statistical 184 
significance using the non-parametric Wilcoxon test. Differences were regarded as 185 
significant when P ≤ 0.05. 186 
 187 
Results 188 
Improved physical barrier in co-culture. The barrier properties of the co-culture model 189 
were monitored by transepithelial resistance (TER), a measure of the ionic 190 
permeability. As shown in Figure 2A, the TER in the co-cultures was significantly 191 
increased from day 1 of culture compared to epithelial mono-cultures. At day 3 of 192 
culture, a maximum was reached with the co-cultures showing more than a 2-fold 193 
increase in TER compared with epithelial mono-cultures. Over the following days the 194 
TER was slightly reduced in the co-cultures, but remained around 2-fold higher than 195 
the epithelial mono-cultures. The close proximity of the epithelial and endothelial 196 
cells in the co-culture model was important for the observed decrease in ionic 197 
permeability in the co-cultures, since culturing the endothelial cells at the bottom of 198 
the culture plate rather than directly on the basolateral side of the permeable filter 199 
support resulted in a smaller increase in TER (Figure 2B). Furthermore, soluble 200 
factors released by endothelial cells triggered the increase in epithelial TER, since 201 
conditioned media from endothelial cells caused a 1.5-fold increase in TER (Figure 202 
2C). However, this increase caused by conditioned media was lower than the 203 
increase in TER observed in the co-culture model again confirming the importance of 204 
the close proximity of the two cell types.  205 
Morphology of co-cultures. Epithelial and endothelial cells were cultured together in 206 
close proximity for a period in which the polarisation of the epithelial layer occurred. 207 
After 6-8 days in culture, immunofluorescence microscopy showed that epithelial 208 
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cells in either mono- or co-culture had zonular apicolateral staining at cell-cell 209 
contacts with antibodies specific for the tight junction protein, occludin, with F-actin 210 
showing a broadly similar organization (Figure 3A-D). However, in the co-cultures 211 
the occludin was more regularly organised at the subapical lateral regions of the 212 
cells (Figure 3E and F) and the thickness of the epithelial cell sheet (10.82µm ± 0.83 213 
mean±SD) was significantly reduced compared with monocultures (21.15µm ± 3.34 214 
mean±SD; p=0.0214; paired t-test). Electron microscopy confirmed that the epithelial 215 
cells in the co-cultures had formed a more even cell sheet with a pseudostratified 216 
structure whereas the epithelial monocultures showed little evidence of stratification 217 
and the apical surface was more irregular (Figure 3G and H). 218 
Effect of Poly(I:C) on physical barrier. As previously reported (15), apical exposure of 219 
polarised epithelial monocultures to double-stranded RNA (Poly(I:C)), a virus-220 
associated molecular pattern that mimics viral infections, caused a reduction in the 221 
TER as early as 3h after exposure (Figure 4A). The minimum occurred 6h after 222 
exposure with a level that was around 50% lower than the untreated control, and 223 
there was a slight recovery by 24h after exposure. In the co-culture, a similar 224 
response to Poly(I:C) was detected with a drop in TER 3h after exposure and a 50% 225 
decrease compared with the untreated control. However, the absolute TER value of 226 
the co-cultures with Poly(I:C) treatment remained higher and was at the same level 227 
of the untreated epithelial monoculture. Both epithelial mono-cultures and epithelial-228 
endothelial co-cultures showed a dose-dependent reduction in TER after stimulation 229 
with Poly(I:C) for 24h (Figure 4B). Although Poly(I:C) caused a significant increase in 230 
ionic permeability, this was associated with only small increases in macromolecular 231 
permeability as determined by passage of FITC-dextran (Figure 4C), but again the 232 
overall permeability of the co-cultures was lower and was similar to the untreated 233 
epithelial monoculture. In contrast to cultures containing epithelial cells, the 234 
endothelial cell monocultures had comparatively low TER values (25Ω*cm2) 235 
compared to epithelial cells (564.7Ω*cm2±72.6 SEM) and epithelial-endothelial co-236 
cultures (1053.9Ω*cm2± 104.7 SEM). Additionally, endothelial cells exhibited 40-50 237 
times higher macromolecular permeability, suggesting that the epithelial cells 238 
contributed most to the tight barrier properties of the co-culture. 239 
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Using static culture conditions, we analysed mediator release in response to Poly(I:C) 240 
challenge(Suppl. Figure 1). TNF-α release was significantly increased by Poly(I:C) in 241 
epithelial monocultures and co-cultures, while endothelial monocultures released 242 
very low levels of TNF-α which were reduced after Poly(I:C) treatment (Suppl. Figure 243 
1A). Poly(I:C) not only stimulated release of CX3CL1 in the co-culture (Suppl. Figure 244 
1B), but also directly stimulated CX3CL1 release from endothelial cells. Interestingly, 245 
the baseline levels of released CX3CL1 were increased in the co-culture, an effect 246 
that might be caused by soluble factors released by epithelial cells. Taken together, 247 
our data suggested that Poly(I:C) drives epithelial release of TNF-α and endothelial 248 
release of CX3CL1. 249 
Kinetic of mediator release. Using a microfluidic culture system (Figure 1), we were 250 
able to analyse the kinetics of mediator release in co-cultures and epithelial mono-251 
cultures. As shown in Figure 5A, Poly(I:C) induced release of TNF-α which peaked 252 
as early as 4h and was reduced to background level 8h after stimulation. The 253 
kinetics of TNF-α release was comparable in epithelial monocultures and co-cultures, 254 
however, consistent with the static culture system, release of TNF-α in the co-culture 255 
was slightly lower than in epithelial monocultures. This might be explained by 256 
utilization of TNF-α binding to receptors present on endothelial cells. Similar to the 257 
static cultures, CX3CL1 release was only detected in the co-cultures and not in 258 
epithelial monocultures, suggesting that the CX3CL1 release is derived from the 259 
endothelial cells (Figure 5B). In the co-cultures, maximal CX3CL1 release occurred 260 
8h after stimulation and returned to baseline level by 18h.  261 
Regulation of endothelial CX3CL1 release. Although Poly(I:C) was able to directly 262 
stimulate CX3CL1 release by endothelial cells, the changes in macromolecular 263 
permeability of the epithelial-endothelial cell co-cultures were low, suggesting that 264 
little Poly(I:C) would penetrate across the epithelial barrier and come into direct 265 
contact with the endothelial cells. However, the timing of cytokine release detected 266 
using the microfluidic culture system suggested that the epithelial-derived TNF-α 267 
observed 4h after stimulation might trigger endothelial CX3CL1 release observed 8h 268 
after stimulation. To test this hypothesis, we used Etanercept, a soluble TNF-α 269 
receptor to antagonize the effect of TNF-α. This caused a significant reduction of 270 
CX3CL1 release by the co-cultures after Poly(I:C) stimulation (Figure 6), indicating 271 
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that cellular cross talk is occurring with epithelial derived TNF-α driving the release of 272 
endothelial CX3CL1, rather than the Poly(I:C) directly stimulating the endothelial cells. 273 
In contrast, blocking TNF-α did not alter the Poly(I:C)-induced effect on TER (Suppl. 274 
Figure 2A+B).  275 
Expression of endothelial adhesion molecules. After Poly(I:C) stimulation, the 276 
expression of endothelial adhesion molecules in epithelial-endothelial co-cultures 277 
was analysed by fluorescence microscopy. As shown in Figure 7, the endothelial 278 
cells showed an increased expression of the adhesion molecules, ICAM-1 and E-279 
selectin after Poly(I:C) stimulation of the co-cultures. This increase in expression was 280 
reduced by neutralizing TNF-α, indicating that epithelial-derived TNF-α also 281 
triggered the expression of endothelial adhesion molecules in response to double-282 
stranded RNA. 283 
 284 
Discussion 285 
In this study, we demonstrated that cellular crosstalk plays an important role in co-286 
ordinating barrier functions of the airway epithelium and endothelium. Through use of 287 
a close contact co-culture model, we showed that the epithelial barrier properties are 288 
enhanced, an effect that is mediated by the presence of endothelial-derived 289 
mediators. In conjunction, we observed morphological changes of the epithelium 290 
suggesting that endothelial cells support the maturation of the epithelium into a 291 
pseudostratified layer, although complete differentiation into a mucociliary epithelium 292 
was not observed. Furthermore, in response to double-stranded RNA (Poly(I:C)), the 293 
epithelium responds rapidly and transiently by releasing TNF-α which activates 294 
endothelial cells to produce CX3CL1 and express adhesion molecules. This co-295 
ordinated response is important in regulating immune cell transmigration across the 296 
endothelial barrier and into the tissue. While microfluidic models of the alveolar-297 
capillary interface have been developed (16, 17), our microfluidic culture model of 298 
the airways allowed us to analyse for the first time the temporal release of these 299 
mediators in response to double-stranded RNA and to show that TNF-α release by 300 
epithelial cells is preceded by, and required for, CX3CL1 release by endothelial cells. 301 
A key advantage of our microfluidic culture system over conventional static culture is 302 
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that it simulates interstitial flow and limits acculmulation of mediators, as occurs in 303 
vivo. Thus, it allows for temporal control of mediator release to be analysed in great 304 
detail, at shorter time intervals, and with a higher sensitivity. This will allow detailed 305 
investigations of the primar or up-stream regulatory mechanisms that control cellular 306 
crosstalk and help to identify key processes that are dysfunctional in diseases, 307 
especially inflammatory chronic lung diseases like asthma and chronic obstructive 308 
pulmonary disease (COPD). Furthermore, this complex dynamic human 3D in vitro 309 
model has the potential to reduce and replace animal experiments for analysing 310 
pathological mechanisms underlying chronic lung diseases, as animal models have 311 
only limited transferability into the human disease (18). 312 
Improvement of the physical barrier properties during lung epithelial-endothelial co-313 
cultures has been shown previously. For example, Chowdhury et al. (19) reported 314 
improved physical barrier properties measured by TER in an airway epithelial-315 
endothelial co-culture model, an effect that was mediated by endothelial derived 316 
factors. However, they did not observe morphological changes in the airway 317 
epithelium in the co-cultures. This might be due to a difference in the co-culture 318 
model, since the endothelial cells were introduced after completion of epithelial 319 
polarisation while in the current study, epithelial and endothelial cells were co-320 
cultured during the period of epithelial polarisation. Interestingly, this barrier 321 
improving effect of endothelial cells seems to be tissue specific, since endothelial 322 
cells derived from brain tissue have been reported to cause a weakening of the 323 
physical barrier of lung epithelial cells (5). Reduced barrier properties have also been 324 
reported in retinal epithelial and endothelial co-cultures (20). The endothelial-derived 325 
factors mediating the enhancing or reducing effects on the epithelial barrier and the 326 
mechanisms are still unknown. 327 
Poly(I:C), an analogue of double-stranded RNA that mimics viral replication, has 328 
been evaluated for its effects on airway barrier functions previously. Airway epithelial 329 
cells express various pattern-recognition receptors (PRRs) to sense double-stranded 330 
RNA, including toll-like receptor 3 (TLR3), protein kinase D (PKD) and cytoplasmic 331 
helicases like RIG-I and MDA5 (15, 21). Similar to our data, increased ionic 332 
permeability has been detected within the first 3h after exposure of polarised 333 
16HBE14o- cells to Poly(I:C) and this was linked to an increase in macromolecular 334 
permeability (15). The decrease in physical barrier integrity has been associated with 335 
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disassembly of adherens and tight junction proteins, a process that is thought to be 336 
mediated by PKD (15). However, although Poly(I:C) increased the ionic permeability 337 
of the co-culture, the effect on macromolecular permeability was small and the 338 
permeability was similar to that of untreated epithelial monocultures which exhibit 339 
good barrier properties and low macromolecular permeability. Consequently, it 340 
seemed unlikely that apically applied Poly(I:C) would be able to penetrate the 341 
epithelial barrier to directly activate the underlying endothelial cells. 342 
Double-stranded RNA is also able to induce the release of inflammatory mediators 343 
by airway epithelial cells, which include the release of CXCL8/IL-8, CXCL10/IP-10, 344 
IFN-β and TNF-α (22). Here we show that double-stranded RNA induced the release 345 
of TNF-α by airway epithelial cells. TNF-α is an important inflammatory mediator that 346 
acts on many cell types including fibroblasts, endothelial cells and immune cells as 347 
well as epithelial cells themselves. For example, exposure of differentiated bronchial 348 
epithelial cells to TNF-α over 4 days resulted in an increased ionic and 349 
macromolecular permeability of the barrier and stimulated release of cytokines and 350 
metalloproteases (23). TNF-α is also thought to trigger mucus production in airway 351 
epithelial cells (24). However, in vivo, release of mediators shows a time-352 
dependency that facilitates cellular crosstalk in response to environmental impacts. 353 
Using a dynamic microfluidic in vitro culture system that simulates interstitial flow, we 354 
have been able to analyse the kinetics of the mediator release with a higher 355 
sensitivity and accuracy compared to conventional static culture conditions (11). By 356 
using this dynamic culture system in combination with the epithelial-endothelial co-357 
culture model, we were able to show that epithelial cells release TNF-α rapidly after 358 
challenge with Poly(I:C), peaking 4 hours after exposure and falling to basal levels 359 
by 10-12 hours. Although we showed that endothelial cells can respond to direct 360 
stimulation by Poly(I:C), in the co-culture system with both epithelial and endothelial 361 
barriers acting in a co-ordinated fashion, early release of TNF-α by airway epithelial 362 
cells was shown to be responsible for endothelial cell release of CX3CL1. Epithelial-363 
derived TNF-α also induced the expression of the adhesion molecules ICAM-1 and 364 
E-selectin.  365 
TNF-α is a well-known regulator of endothelial functions and its mechanisms were 366 
studied extensively (25, 26). Using endothelial monocultures, induction of CX3CL1 367 
Page 12 of 34Immunity, Inflammation and Disease
13 
 
after stimulation with exogenous TNF-α has been shown previously (27, 28). By 368 
facilitating kinetic profiling, the microfluidic co-culture system has enabled 369 
identification of TNF-α as a key endogenous signalling mechanism between the 370 
epithelial and endothelial barriers. It is thought that TNF-α induces the transcription 371 
of CX3CL1 by a phosphatidylinositol 3’-kinase and NF-κB mediated pathway (27). 372 
Additionally, TNF-α has been shown to stabilise CX3CL1 mRNA via a p38 MAPK 373 
dependent mechanism on a post-transcriptional level, which results in synergistically 374 
induced CX3CL1 expression in HUVECs after TNF-α and IFN-γ stimulation (28). 375 
Released soluble CX3CL1 is involved in leukocyte trafficking by attracting and 376 
activating CD8+ and CD4+ T cells, natural killer cells, dendritic cells and monocytes 377 
(29). There is evidence that CX3CL1 is linked to inflammatory chronic lung diseases 378 
as raised levels of CX3CL1 have been shown in asthma and COPD (30, 31).  379 
Activation of endothelial cells by TNF-α also results in the expression of adhesion 380 
molecules facilitating the transmigration of leukocytes across the endothelial barrier. 381 
For example, TNF-α is a well-known inducer of endothelial adhesion molecule 382 
expression like E-selectin and ICAM-1 which is mediated by the NF-κB and AP-1 383 
signalling pathways (25, 26). Recent data showed that the expression of E-selectin is 384 
induced by TNF-α by a p66Shc and JNK-mediated pathway and results in increased 385 
transmigration of leukocytes (32). Since blockade of TNF-α only partially prevents 386 
endothelial activation, other epithelial-derived factors, such as IL-8 or IFN-β, may 387 
contribute to endothelial activation. IL-8 has been shown to initiate the reorganisation 388 
of the endothelial cytoskeleton (33) and IFN-β modulates endothelial expression of 389 
ICAM-1 and MHC class I and II molecules (34). 390 
After endothelial activation the recruitment of immune cells is mediated by a highly 391 
regulated adhesion cascade including the capture, rolling, crawling and finally the 392 
transmigration of the immune cell across the endothelial barrier, a process that has 393 
been intensively studied (35, 36). Since TNF-α plays a central role in the regulation 394 
of inflammation, TNF-blocking biologicals are already approved for the treatment of 395 
inflammatory diseases including rheumatoid arthritis, inflammatory bowel disease 396 
and psoriasis (37, 38). The efficacy of anti-TNF-α drugs in pulmonary inflammatory 397 
diseases such as asthma has been investigated (39-41), as well as the use of other 398 
non-biological drugs like polyphenols (42). However, the role of TNF-α mediated 399 
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endothelial activation in virally induced lung inflammation is less well characterised. 400 
Since viral infections are the most common trigger of exacerbations in chronic lung 401 
diseases like asthma and COPD, targeting adhesion molecules involved in immune 402 
cell recruitment is a promising therapeutic strategy (43). Using an epithelial-403 
endothelial co-culture model in combination with a dynamic culture platform allows 404 
us to identify a key signalling mechanism between the epithelial and endothelial 405 
barriers. This should enhance our understanding of the regulatory mechanisms 406 
during airway inflammation and contribute to the identification of new, more effective 407 
drugs targeting chronic airway inflammation. Additionally, the dynamic co-culture 408 
model of the airway mucosa is an ideal tool for testing candidate drugs for their 409 
efficacy in the pre-clinical phase, since it incorporates the aspect of cellular crosstalk 410 
and the dynamic flow of metabolites observed in vivo.  411 
Limitations of the study. The aim of this study was to highlight the potential for 412 
utilisation of microfluidic culture systems with epithelial-endothelial co-culture models 413 
to enable kinetic analysis of the mediators involved in cell-cell communication 414 
between the epithelial and endothelial barriers. In order to facilitate uptake of the 415 
model by the scientific community and to ensure accessibility to human cell material, 416 
we utilised an airway epithelial cell line (16HBE) that forms a polarised barrier in 417 
culture and human umbilical cord endothelial cells (HUVECs). Both cell types have 418 
been used extensively to study airway epithelial and endothelial functions. For 419 
example, we and others have found that 16HBE cells and fully differentiated primary 420 
bronchial epithelial cells respond similar to challenge with pollen (44) or Poly(I:C) 421 
(45). However, in future work it will be important to evaluate the co-culture model 422 
using fully differentiated primary bronchial epithelial cells and pulmonary (or 423 
bronchial) microvascular endothelial cells. Furthermore, while we elected to use 424 
Poly(I:C) as a proto-typical pathogen-associated molecular pattern (PAMP) that 425 
mimics the production of double-stranded RNA during wiral replication, this only 426 
reflects one aspect of viral infection. In order to reflect the complexity of human 427 
rhinovirus infections, further work would be required using infectious respiratory 428 
viruses.  429 
430 
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 588 
Figure Legends 589 
Fig. 1: Design of the microfluidic culture system. A: A photoresist dry film forming 590 
the microfluidic channel is laminated onto a support layer on which a holder is fixed. 591 
A permeable Transwell® support is inserted and sealed by a V-ring. B: Schematic 592 
section of a epithelial-endothelial co-culture under microfluidic culture conditions.  593 
 594 
Fig. 2: Enhanced barrier properties in epithelial-endothelial co-cultures. The 595 
integrity of the epithelial and endothelial barriers was monitored by measuring the 596 
transepithelial (or endothelial) resistance (TER). A: Epithelial cells (EPI) were 597 
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cultured on the apical and endothelial cells (ENDO) on the basolateral side of 598 
permeable filter supports for up to 6 days (Mean±SEM, n=11-16 independent 599 
experiments). B: Comparison of TER measurements on day 3 of epithelial mono-600 
cultures (clear bar), epithelial-endothelial co-culture in close proximity on filter 601 
supports (black bar) and co-cultures with endothelial cells grown on the bottom of the 602 
well at a distance to epithelial cells (grey bar) (Mean±SEM; n=7 independent 603 
experiments; *: p≤0.05 compared to EPI (Wilcoxon)). C: Effect of endothelial cell 604 
conditioned medium on TER of epithelial cells after 3 days of culture. TER was 605 
normalised to the TER of epithelial monocultures (Mean±SEM; n=10 independent 606 
experiments; *: p≤0.05 (Wilcoxon)). 607 
 608 
Fig. 3: Epithelial cells change the morphology during co-culture with 609 
endothelial cells. Epithelial (EPI) and endothelial cells (ENDO) were co-cultured for 610 
6-8 days (right panels) and the morphology of the epithelial cells compared to 611 
epithelial monocultures (left panels) by microscopy. Analysis by fluorescence 612 
microscopy was performed using an anti-occludin antibody (green, panels A and B) 613 
and an actin filament specific dye (red, panels C and D). A z-projection of the 614 
epithelial cell layer is shown. E and F: Orthogonal views of the z-stacks. G and H: 615 
Electron scanning microscopy images of epithelial monoculture (G) and epithelial-616 
endothelial co-culture (H). Images are representative of 3 independent experiments. 617 
 618 
Fig. 4: Effect of Poly(I:C) on the physical barrier properties. Epithelial (EPI) and 619 
endothelial cells (ENDO) were co-cultured for 6 days and subsequently exposed 620 
apically with Poly(I:C), a mimic of viral double-stranded RNA. Epithelial and 621 
endothelial monocultures were used as controls. A: Time-dependent changes of the 622 
ionic permeability measured by transepithelial resistance (TER) after stimulation with 623 
5µg/ml Poly(I:C) (Mean±SEM; n=8 independent experiments). B: Dose-dependent 624 
effect of Poly(I:C) on the TER of epithelial monocultures and co-cultures at 24h. The 625 
TER at t=24h is normalised to the TER at t=0h (Mean±SEM, n=8 independent 626 
experiments; *: p≤0.05 compared to untreated control (Wilcoxon)). C: Macro-627 
molecular permeability of the barrier after Poly(I:C) stimulation. Mono- or co-cultures 628 
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were apically exposed with FITC-dextran after 21h of Poly(I:C) stimulation and the 629 
passage of FITC-dextran into the basolateral compartment was calculated by 630 
measuring the fluorescence intensity after 3h (Mean±SEM, n=5 independent 631 
experiments). 632 
 633 
Fig. 5: Time-dependent release of mediators after Poly(I:C) stimulation. After 6 634 
days in culture, epithelial monocultures or co-cultures were transferred to the 635 
microfluidic culture system and apically stimulated with 5µg/ml Poly(I:C). The 636 
basolateral flow through was collected in 2h intervals with an automated fraction 637 
collector and mediator release analysed by ELISA. A: Basolateral release of TNF-α 638 
in response to Poly(I:C). B: Time-dependent release of CX3CL1 (fractalkine). 639 
Mean±SEM, n=7-8 independent experiments. 640 
 641 
Fig. 6: Anti-TNF-α attenuates the Poly(I:C) induced release of CX3CL1 642 
(fractalkine ) in the co-cultures. Co-cultures under static conditions were pre-643 
incubated for 1h with anti-TNF-α and subsequently stimulated with Poly(I:C) apically. 644 
Basolateral release of CX3CL1 (fractalkine) was analysed after 24h by ELISA. 645 
Mean±SEM, n=5 independent experiments; *: p≤0.05 (one-tailed paired t-test). 646 
 647 
Fig. 7: Poly(I:C) induced expression of endothelial adhesion molecules is 648 
inhibited by anti-TNF-α treatment in the co-cultures. Co-cultures were pre-649 
treated with anti-TNF-α for 1h cultures and subsequently stimulated with 5µg/ml 650 
Poly(I:C) apically. Expression of ICAM-1 (left panels) and E-selectin (right panels) 651 
was analysed by fluorescence microscopy after 24h. Images are representative of 3 652 
independent experiments. 653 
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Figure 1: Design of the microfluidic culture system. A: A photoresist dry film forming the microfluidic 
channel is laminated onto a support layer on which a holder is fixed. A permeable Transwell® support is 
inserted and sealed by a V-ring. B: Schematic section of a epithelial-endothelial co-culture under microfluidic 
culture conditions.  
Figure 1  
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Figure 2: Enhanced barrier properties in epithelial-endothelial co-cultures. The integrity of the epithelial and 
endothelial barriers was monitored by measuring the transepithelial (or endothelial) resistance (TER). A: 
Epithelial cells (EPI) were cultured on the apical and endothelial cells (ENDO) on the basolateral side of 
permeable filter supports for up to 6 days (Mean±SEM, n=11-16 independent experiments). B: Comparison 
of TER measurements on day 3 of epithelial mono-cultures (clear bar), epithelial-endothelial co-culture in 
close proximity on filter supports (black bar) and co-cultures with endothelial cells grown on the bottom of 
the well at a distance to epithelial cells (grey bar) (Mean±SEM; n=7 independent experiments; *: p≤0.05 
compared to EPI (Wilcoxon)). C: Effect of endothelial cell conditioned medium on TER of epithelial cells after 
3 days of culture. TER was normalised to the TER of epithelial monocultures (Mean±SEM; n=10 independent 
experiments; *: p≤0.05 (Wilcoxon)).  
Figure 2  
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Figure 3: Epithelial cells change the morphology during co-culture with endothelial cells. Epithelial (EPI) and 
endothelial cells (ENDO) were co-cultured for 6-8 days (right panels) and the morphology of the epithelial 
cells compared to epithelial monocultures (left panels) by microscopy. Analysis by fluorescence microscopy 
was performed using an anti-occludin antibody (green, panels A and B) and an actin filament specific dye 
(red, panels C and D). A z-projection of the epithelial cell layer is shown. E and F: Orthogonal views of the z-
stacks. G and H: Electron scanning microscopy images of epithelial monoculture (G) and epithelial-
endothelial co-culture (H). Images are representative of 3 independent experiments.  
Figure 3  
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Figure 4: Effect of Poly(I:C) on the physical barrier properties. Epithelial (EPI) and endothelial cells (ENDO) 
were co-cultured for 6 days and subsequently exposed apically with Poly(I:C), a mimic of viral double-
stranded RNA. Epithelial and endothelial monocultures were used as controls. A: Time-dependent changes of 
the ionic permeability measured by transepithelial resistance (TER) after stimulation with 5µg/ml Poly(I:C) 
(Mean±SEM; n=8 independent experiments). B: Dose-dependent effect of Poly(I:C) on the TER of epithelial 
monocultures and co-cultures at 24h. The TER at t=24h is normalised to the TER at t=0h (Mean±SEM, n=8 
independent experiments; *: p≤0.05 compared to untreated control (Wilcoxon)). C: Macro-molecular 
permeability of the barrier after Poly(I:C) stimulation. Mono- or co-cultures were apically exposed with FITC-
dextran after 21h of Poly(I:C) stimulation and the passage of FITC-dextran into the basolateral 
compartment was calculated by measuring the fluorescence intensity after 3h (Mean±SEM, n=5 independent 
experiments).  
Figure 4  
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Figure. 5: Time-dependent release of mediators after Poly(I:C) stimulation. After 6 days in culture, epithelial 
monocultures or co-cultures were transferred to the microfluidic culture system and apically stimulated with 
5µg/ml Poly(I:C). The basolateral flow through was collected in 2h intervals with an automated fraction 
collector and mediator release analysed by ELISA. A: Basolateral release of TNF-α in response to Poly(I:C). 
B: Time-dependent release of CX3CL1 (fractalkine). Mean±SEM, n=7-8 independent experiments.  
Figure 5  
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Figure 6: Anti-TNF-α attenuates the Poly(I:C) induced release of CX3CL1 (fractalkine ) in the co-cultures. 
Co-cultures under static conditions were pre-incubated for 1h with anti-TNF-α and subsequently stimulated 
with Poly(I:C) apically. Basolateral release of CX3CL1 (fractalkine) was analysed after 24h by ELISA. 
Mean±SEM, n=5 independent experiments; *: p≤0.05 (one-tailed paired t-test).  
Figure 6  
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Fig. 7: Poly(I:C) induced expression of endothelial adhesion molecules is inhibited by anti-TNF-α treatment 
in the co-cultures. Co-cultures were pre-treated with anti-TNF-α for 1h cultures and subsequently stimulated 
with 5µg/ml Poly(I:C) apically. Expression of ICAM-1 (left panels) and E-selectin (right panels) was analysed 
by fluorescence microscopy after 24h. Images are representative of 3 independent experiments.  
Figure 7  
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